Second pivotal trial of TWIN for the treatment of acne vulgaris in USA

Trial Profile

Second pivotal trial of TWIN for the treatment of acne vulgaris in USA

Planning
Phase of Trial: Phase III

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs Benzoyl peroxide/tretinoin (Primary)
  • Indications Acne vulgaris
  • Focus Registrational; Therapeutic Use
  • Sponsors Sol-Gel Technologies
  • Most Recent Events

    • 26 Mar 2018 According to the Sol-Gel Technologies, this trial is anticipated to start in the second half of 2018.
    • 05 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top